BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35212389)

  • 21. Toward Prevention of Mild Cognitive Impairment in Older Adults With Depression: An Observational Study of Potentially Modifiable Risk Factors.
    Gallagher D; Kiss A; Lanctot KL; Herrmann N
    J Clin Psychiatry; 2018 Nov; 80(1):. PubMed ID: 30549490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Observational study of patient characteristics associated with a timely diagnosis of dementia and mild cognitive impairment without dementia.
    White L; Ingraham B; Larson E; Fishman P; Park S; Coe NB
    J Gen Intern Med; 2022 Sep; 37(12):2957-2965. PubMed ID: 34647229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current and Future Prevalence Estimates of Mild Cognitive Impairment, Dementia, and Its Subtypes in a Population-Based Sample of People 70 Years and Older in Norway: The HUNT Study.
    GjØra L; Strand BH; Bergh S; Borza T; Brækhus A; Engedal K; Johannessen A; Kvello-Alme M; Krokstad S; Livingston G; Matthews FE; Myrstad C; Skjellegrind H; Thingstad P; Aakhus E; Aam S; Selbæk G
    J Alzheimers Dis; 2021; 79(3):1213-1226. PubMed ID: 33427745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting.
    Roberts RO; Aakre JA; Kremers WK; Vassilaki M; Knopman DS; Mielke MM; Alhurani R; Geda YE; Machulda MM; Coloma P; Schauble B; Lowe VJ; Jack CR; Petersen RC
    JAMA Neurol; 2018 Aug; 75(8):970-979. PubMed ID: 29710225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Martínez G; Vernooij RW; Fuentes Padilla P; Zamora J; Bonfill Cosp X; Flicker L
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012216. PubMed ID: 29164603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The epidemiology of mild cognitive impairment, Alzheimer's disease and related dementia in U.S. veterans.
    Dinesh D; Shao Q; Palnati M; McDannold S; Zhang Q; Monfared AAT; Jasuja GK; Davila H; Xia W; Moo LR; Miller DR; Palacios N
    Alzheimers Dement; 2023 Sep; 19(9):3977-3984. PubMed ID: 37114952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of cognitively impaired patients at risk for development of Alzheimer's disease dementia: an analysis of US Medicare claims data.
    Potashman M; Parcher B; Zhou J; Hou Q; Stefanacci R
    Expert Rev Pharmacoecon Outcomes Res; 2022 Jul; 22(5):773-786. PubMed ID: 35196953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The age-specific comorbidity burden of mild cognitive impairment: a US claims database study.
    Li G; Toschi N; Devanarayan V; Batrla R; Boccato T; Cho M; Ferrante M; Frech F; Galvin JE; Henley D; Mattke S; De Santi S; Hampel H
    Alzheimers Res Ther; 2023 Dec; 15(1):211. PubMed ID: 38057937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severity Distribution of Alzheimer's Disease Dementia and Mild Cognitive Impairment in the Framingham Heart Study.
    Yuan J; Maserejian N; Liu Y; Devine S; Gillis C; Massaro J; Au R
    J Alzheimers Dis; 2021; 79(2):807-817. PubMed ID: 33361590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Body Mass Index Trajectories Preceding Incident Mild Cognitive Impairment and Dementia.
    Guo J; Wang J; Dove A; Chen H; Yuan C; Bennett DA; Xu W
    JAMA Psychiatry; 2022 Dec; 79(12):1180-1187. PubMed ID: 36287554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Incarceration as a Risk Factor for Cognitive Impairment.
    Cox RJA; Wallace RB
    J Gerontol B Psychol Sci Soc Sci; 2022 Dec; 77(12):e247-e262. PubMed ID: 36153747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
    Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
    Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of Mild Cognitive Impairment and Alzheimer's Disease Identified in Veterans in the United States.
    Aguilar BJ; Jasuja GK; Li X; Shishova E; Palacios N; Berlowitz D; Morin P; O'Connor MK; Nguyen A; Reisman J; Leng Y; Zhang R; Monfared AAT; Zhang Q; Xia W
    J Alzheimers Dis; 2024; 99(3):1065-1075. PubMed ID: 38788073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conversion to dementia in mild cognitive impairment diagnosed with DSM-5 criteria and with Petersen's criteria.
    Marcos G; Santabárbara J; Lopez-Anton R; De-la-Cámara C; Gracia-García P; Lobo E; Pírez G; Menchón JM; Palomo T; Stephan BC; Brayne C; Lobo A;
    Acta Psychiatr Scand; 2016 May; 133(5):378-85. PubMed ID: 26685927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic test accuracy of telehealth assessment for dementia and mild cognitive impairment.
    McCleery J; Laverty J; Quinn TJ
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013786. PubMed ID: 34282852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mild Cognitive Impairment and Dementia Reported by Former Professional Football Players over 50 yr of Age: An NFL-LONG Study.
    Walton SR; Brett BL; Chandran A; Defreese JD; Mannix R; Echemendia RJ; Meehan WP; McCrea M; Guskiewicz KM; Kerr ZY
    Med Sci Sports Exerc; 2022 Mar; 54(3):424-431. PubMed ID: 34593716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comorbid Mild Cognitive Impairment and Depressive Symptoms Predict Future Dementia in Community Older Adults: A 24-Month Follow-Up Longitudinal Study.
    Makizako H; Shimada H; Doi T; Tsutsumimoto K; Hotta R; Nakakubo S; Makino K; Suzuki T
    J Alzheimers Dis; 2016 Oct; 54(4):1473-1482. PubMed ID: 27589518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropsychiatric Symptoms and Cognitive Impairment: Understanding the Importance of Co-Morbid Symptoms.
    Mortby ME; Burns R; Eramudugolla R; Ismail Z; Anstey KJ
    J Alzheimers Dis; 2017; 59(1):141-153. PubMed ID: 28598846
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.